《展望治疗》向投资者介绍2024年财政年度业绩和未来计划的最新情况。 Outlook Therapeutics updates investors on fiscal year 2024 performance and future plans.

《展望治疗》公布了2024财政年度的财务结果,并提供了关于其公司状况的最新资料。 Outlook Therapeutics has released its financial results for fiscal year 2024 and provided an update on its corporate status. 该公司侧重于开发药品,分享了其财务业绩和未来计划的详细情况,但没有披露具体数字。 The company, focused on developing pharmaceuticals, shared details on its financial performance and future plans without disclosing specific figures. 这一更新的目的是向投资者和利益攸关方通报公司目前的金融健康和战略方向。 This update is intended to inform investors and stakeholders about the company's current financial health and strategic direction.